CBP wins approval for production of human albumin

According to the company, the human albumin 12.5g/vial (25%, 50ml), contains the highest concentration and delivers the highest dosage of the human albumin family products in Mainland China, and has a better effect on the clinical application for ascites due to liver cirrhosis, external injuries, hydrocephalus due to cerebral hemorrhage, serious hypoproteinemia, and other major diseases.

With this approval, China Biologic Products (CBP) is said to have become one of the few producers offering the widest range of human albumin products available in China. The company has already commenced the production and marketing of this new product.